Immunocore Holdings plc
IMCR
$37.20
$1.945.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.33% | 120.56% | -20.48% | 864.24% | 31.73% |
| Total Depreciation and Amortization | -21.37% | -15.53% | 12.98% | -3.90% | -3.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.30% | -79.73% | -22.04% | -150.73% | -48.93% |
| Change in Net Operating Assets | -1.79% | -193.49% | 60.18% | 67.39% | 958.06% |
| Cash from Operations | 10.62% | 109.48% | 21.33% | 109.41% | 52,060.00% |
| Capital Expenditure | -25.08% | 30.70% | -338.68% | -290.57% | 76.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.43% | -- | -- | -- | -- |
| Cash from Investing | 91.32% | 2,356.28% | -333.29% | -290.57% | -25,013.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,131.54% | -55.67% | -91.21% | -98.09% | -97.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 548.66% | -99.36% | -923.65% | -98.09% | -107.07% |
| Foreign Exchange rate Adjustments | 7,564.15% | 1,153.25% | -220.86% | 251.48% | -104.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.38% | -94.59% | -5,325.66% | 169.97% | -2,507.37% |